GOLD DANIEL P PHD 4
4 · MEI Pharma, Inc. · Filed Oct 1, 2019
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2019-09-27$1.57/sh+20,000$31,400→ 342,882 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-09-27−20,000→ 287,500 totalExercise: $1.57Exp: 2025-07-28→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]All of the options are fully vested and currently exercisable.